NPH insulin : It remains a good option
NPH insulin: It remains a good option. NPH insulin holds its own against basal insulin analogs - and it's cheaper. PRACTICE CHANGER: Consider NPH insulin for patients who require initiation of long-acting insulin therapy because it is as safe as, and more cost-effective than, basal insulin analogs. STRENGTH RECOMMENDATION: B: Based on a single, large, retrospective, observational study.
Journal of Family Practice, 69(02) 2020: 94-95.